John R. Hess focuses on Intensive care medicine, Surgery, Resuscitation, Blood transfusion and Coagulopathy. His Intensive care medicine study combines topics from a wide range of disciplines, such as Red blood cell, Immunology, Clinical trial and Damage control surgery. His research integrates issues of Internal medicine, Fibrinogen and Intensive care unit in his study of Surgery.
His studies deal with areas such as Platelet, Blood Component Transfusion and Randomized controlled trial as well as Resuscitation. He combines subjects such as Blood product, Hepatitis C, Whole blood and Hepatitis C virus with his study of Blood transfusion. His Coagulopathy research includes elements of Hypothermia, Coagulation and Protocol.
His main research concerns Surgery, Internal medicine, Intensive care medicine, Anesthesia and Resuscitation. His study in Surgery is interdisciplinary in nature, drawing from both Fibrinogen, Fresh frozen plasma, Animal science and Fibrin. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Endocrinology and Cardiology.
In his study, Blood product and Medical emergency is inextricably linked to Blood transfusion, which falls within the broad field of Intensive care medicine. His Anesthesia research incorporates elements of Hemostasis and Platelet. His research investigates the link between Resuscitation and topics such as Coagulopathy that cross with problems in Hypothermia.
The scientist’s investigation covers issues in Platelet, Internal medicine, Anesthesia, Resuscitation and Blood transfusion. His Platelet study also includes
The Anesthesia study combines topics in areas such as Packed red blood cells and Trauma center. His biological study spans a wide range of topics, including Whole blood, Blood product, Coagulopathy, Total blood and Intensive care medicine. John R. Hess has included themes like Radiation therapy and Radiology in his Blood transfusion study.
John R. Hess mainly focuses on Platelet, Internal medicine, Randomized controlled trial, Injury Severity Score and Emergency medicine. John R. Hess has researched Platelet in several fields, including Whole blood, Massive transfusion, Blood transfusion, Coagulation and Intensive care unit. His Randomized controlled trial study incorporates themes from Anesthesia and Adverse effect.
In most of his Adverse effect studies, his work intersects topics such as Intensive care medicine. His work deals with themes such as Hemostasis, Blood product and Blood plasma, which intersect with Emergency medicine. The study incorporates disciplines such as Surgery and Cohort in addition to Platelet transfusion.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Transfusion of plasma, platelets, and red blood cells in a 1: 1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: The PROPPR randomized clinical trial
John B. Holcomb;Barbara C. Tilley;Sarah Baraniuk;Erin E. Fox.
JAMA (2015)
Damage control resuscitation: Directly addressing the early coagulopathy of trauma
John B. Holcomb;Don Jenkins;Peter Rhee;Jay Johannigman.
Journal of Trauma-injury Infection and Critical Care (2007)
The coagulopathy of trauma: a review of mechanisms.
John R. Hess;Karim Brohi;Richard P. Dutton;Carl J. Hauser.
Journal of Trauma-injury Infection and Critical Care (2008)
Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site.
Steve Bonello;Christian Zähringer;Rachida S. BelAiba;Talija Djordjevic.
Arteriosclerosis, Thrombosis, and Vascular Biology (2007)
Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening.
Manfred Vogt;Thomas Lang;Gert Frösner;Christiane Klingler.
The New England Journal of Medicine (1999)
Dose of prophylactic platelet transfusions and prevention of hemorrhage.
Sherrill J. Slichter;Richard M. Kaufman;Susan F. Assmann;Jeffrey McCullough.
The New England Journal of Medicine (2010)
Massive transfusion practices around the globe and a suggestion for a common massive transfusion protocol.
Debra L Malone;John R Hess;Abe Fingerhut.
Journal of Trauma-injury Infection and Critical Care (2006)
The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital.
Harry K. Stinger;Philip C. Spinella;Jeremy G. Perkins;Kurt W. Grathwohl.
Journal of Trauma-injury Infection and Critical Care (2008)
Blood transfusion rates in the care of acute trauma
John J. Como;Richard P. Dutton;Thomas M. Scalea;Bennett B. Edelman.
Transfusion (2004)
Trauma Mortality in Mature Trauma Systems: Are We Doing Better? An Analysis of Trauma Mortality Patterns, 1997-2008
Richard P. Dutton;Lynn G. Stansbury;Susan Leone;Elizabeth Kramer.
Journal of Trauma-injury Infection and Critical Care (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Maryland, Baltimore
University of Alabama at Birmingham
Technical University of Munich
Northwestern University
Oregon Health & Science University
The University of Texas Health Science Center at Houston
University of Southern California
Johns Hopkins University
Technical University of Munich
The University of Texas Health Science Center at Houston
Carnegie Mellon University
University of Calabria
Université Paris Cité
Korea University
Leiden University
Royal Botanic Gardens
MRC Laboratory of Molecular Biology
University of Arizona
Chinese Academy of Sciences
University of Florida
University of Potsdam
National Oceanography Centre
University of Twente
Israel Oceanographic and Limnological Research
University of Nebraska–Lincoln
Institute of Tropical Medicine Antwerp